151 related articles for article (PubMed ID: 27927168)
1. Phosphodiesterases in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia.
Mahmood B; Damm MM; Jensen TS; Backe MB; Dahllöf MS; Poulsen SS; Bindslev N; Hansen MB
BMC Cancer; 2016 Dec; 16(1):938. PubMed ID: 27927168
[TBL] [Abstract][Full Text] [Related]
2. Transporter function and cyclic AMP turnover in normal colonic mucosa from patients with and without colorectal neoplasia.
Kleberg K; Jensen GM; Christensen DP; Lundh M; Grunnet LG; Knuhtsen S; Poulsen SS; Hansen MB; Bindslev N
BMC Gastroenterol; 2012 Jun; 12():78. PubMed ID: 22734885
[TBL] [Abstract][Full Text] [Related]
3. Expression and distribution of phosphodiesterase isoenzymes in the human seminal vesicles.
Ückert S; Waldkirch ES; Sonnenberg JE; Sandner P; Kuczyk MA; Hedlund P
J Sex Med; 2011 Nov; 8(11):3058-65. PubMed ID: 21810184
[TBL] [Abstract][Full Text] [Related]
4. Possible predisposition for colorectal carcinogenesis due to altered gene expressions in normal appearing mucosa from patients with colorectal neoplasia.
Petersen CH; Mahmood B; Badsted C; Dahlby T; Rasmussen HB; Hansen MB; Bindslev N
BMC Cancer; 2019 Jun; 19(1):643. PubMed ID: 31253108
[TBL] [Abstract][Full Text] [Related]
5. Prostaglandin E2-induced colonic secretion in patients with and without colorectal neoplasia.
Kaltoft N; Tilotta MC; Witte AB; Osbak PS; Poulsen SS; Bindslev N; Hansen MB
BMC Gastroenterol; 2010 Jan; 10():9. PubMed ID: 20100359
[TBL] [Abstract][Full Text] [Related]
6. Combined activity of COX-1 and COX-2 is increased in non-neoplastic colonic mucosa from colorectal neoplasia patients.
Jensen TSR; Mahmood B; Damm MB; Backe MB; Dahllöf MS; Poulsen SS; Hansen MB; Bindslev N
BMC Gastroenterol; 2018 Feb; 18(1):31. PubMed ID: 29486731
[TBL] [Abstract][Full Text] [Related]
7. Cyclic nucleotide phosphodiesterase (PDE) inhibitors: novel therapeutic agents for progressive renal disease.
Cheng J; Grande JP
Exp Biol Med (Maywood); 2007 Jan; 232(1):38-51. PubMed ID: 17202584
[TBL] [Abstract][Full Text] [Related]
8. Nitric oxide-induced changes in endothelial expression of phosphodiesterases 2, 3, and 5.
Schankin CJ; Kruse LS; Reinisch VM; Jungmann S; Kristensen JC; Grau S; Ferrari U; Sinicina I; Goldbrunner R; Straube A; Kruuse C
Headache; 2010 Mar; 50(3):431-41. PubMed ID: 19751368
[TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide phosphodiesterases (PDEs) in human osteoblastic cells; the effect of PDE inhibition on cAMP accumulation.
Ahlström M; Pekkinen M; Huttunen M; Lamberg-Allardt C
Cell Mol Biol Lett; 2005; 10(2):305-19. PubMed ID: 16010295
[TBL] [Abstract][Full Text] [Related]
10. Initial biochemical and functional characterization of cyclic nucleotide phosphodiesterase isozymes in canine colonic smooth muscle.
Barnette MS; Manning CD; Price WJ; Barone FC
J Pharmacol Exp Ther; 1993 Feb; 264(2):801-12. PubMed ID: 7679736
[TBL] [Abstract][Full Text] [Related]
11. Cyclic nucleotide phosphodiesterases (PDEs): coincidence detectors acting to spatially and temporally integrate cyclic nucleotide and non-cyclic nucleotide signals.
Maurice DH; Wilson LS; Rampersad SN; Hubert F; Truong T; Kaczmarek M; Brzezinska P; Freitag SI; Umana MB; Wudwud A
Biochem Soc Trans; 2014 Apr; 42(2):250-6. PubMed ID: 24646226
[TBL] [Abstract][Full Text] [Related]
12. Acetylcholine-related proteins in non-neoplastic appearing colonic mucosa from patients with colorectal neoplasia.
Damm MMB; Jensen TSR; Mahmood B; Lundh M; Poulsen SS; Bindslev N; Hansen MB
Mol Carcinog; 2017 Oct; 56(10):2223-2233. PubMed ID: 28544328
[TBL] [Abstract][Full Text] [Related]
13. The conserved protective cyclic AMP-phosphodiesterase function PDE4B is expressed in the adenoma and adjacent normal colonic epithelium of mammals and silenced in colorectal cancer.
Pleiman JK; Irving AA; Wang Z; Toraason E; Clipson L; Dove WF; Deming DA; Newton MA
PLoS Genet; 2018 Sep; 14(9):e1007611. PubMed ID: 30188895
[TBL] [Abstract][Full Text] [Related]
14. Targeting the paracrine hormone-dependent guanylate cyclase/cGMP/phosphodiesterases signaling pathway for colorectal cancer prevention.
Yarla NS; Gali H; Pathuri G; Smriti S; Farooqui M; Panneerselvam J; Kumar G; Madka V; Rao CV
Semin Cancer Biol; 2019 Jun; 56():168-174. PubMed ID: 30189250
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial cell cyclic nucleotide phosphodiesterases and regulated cell migration: implications in angiogenesis.
Netherton SJ; Maurice DH
Mol Pharmacol; 2005 Jan; 67(1):263-72. PubMed ID: 15475573
[TBL] [Abstract][Full Text] [Related]
16. Phosphodiesterases in the central nervous system.
Kleppisch T
Handb Exp Pharmacol; 2009; (191):71-92. PubMed ID: 19089326
[TBL] [Abstract][Full Text] [Related]
17. An update on cyclic nucleotide phosphodiesterase (PDE) inhibitors: phosphodiesterases and drug selectivity.
Gupta R; Kumar G; Kumar RS
Methods Find Exp Clin Pharmacol; 2005 Mar; 27(2):101-18. PubMed ID: 15834463
[TBL] [Abstract][Full Text] [Related]
18. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
White JB; Thompson WJ; Pittler SJ
Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303
[TBL] [Abstract][Full Text] [Related]
19. Cyclic AMP and cyclic GMP levels in human colonic mucosa before and during chenodeoxycholic acid therapy.
Corazza GR; Ciccarelli R; Caciagli F; Gasbarrini G
Gut; 1979 Jun; 20(6):489-92. PubMed ID: 223950
[TBL] [Abstract][Full Text] [Related]
20. A glutamine switch mechanism for nucleotide selectivity by phosphodiesterases.
Zhang KY; Card GL; Suzuki Y; Artis DR; Fong D; Gillette S; Hsieh D; Neiman J; West BL; Zhang C; Milburn MV; Kim SH; Schlessinger J; Bollag G
Mol Cell; 2004 Jul; 15(2):279-86. PubMed ID: 15260978
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
